Skip to main content
SpringerLink
Log in

Gastric cancer in Korea: experience at the Seoul National University Hospital

  • Chapter
Management of Gastric Cancer

Part of the book series: Cancer Treatment and Research ((CTAR,volume 55))

Abstract

Gastric cancer is the most common cancer in Korea and constitutes 24.2% of all malignancies, 29.6% of male tumors, and 17.8% of female tumors [1]. The annual incidence is 69.1 per 100,000 in males and 29.5 per 100,000 in females. The prognosis for gastric carcinoma continues to be unfavorable in this country. The annual death rates are 38.8 per 100,000 for male and 23.9 per 100,000 for female. Surgery can result in cures or longer disease free survivals in only a small number of patients, since most gastric carcinomas are diagnosed when the tumor is at an advanced stage. More than 50% of all patients with newly diagnosed gastric carcinoma at the Seoul National University Hospital (SNUH) had an unresectable, locally advanced disease, and/or distant metastases (Figure 1). While response rates in gastric cancer patients treated with a combination chemotherapy regimen are somewhat better than for colorectal cancer, complete responses are generally uncommon. Thus far, the only treatment that results in a significant cure of gastric cancer is surgery. As the result of surgery depends upon the stage of disease, only early detection has been the best method to cure gastric cancer up to now. In this chapter, we intend to summarize the biologic and pathologic characteristics of gastric cancer, data of detection with radiologic and endoscopic measures, and the results of surgical treatment and chemotherapy regimens utilized at SNUH.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Anon, 1989. Ministry of Health and Social Affairs. Five years report for cancer register programme in the republic of Korea. July 1,1982–June 30,1987. J Korean Cancer Res Assoc 21:1.

    Google Scholar 

  2. Park JG, Frucht H, Larocca RV, et al., 1990. Characteristics of cell lines established from human gastric carcinoma. Cancer Res 50:2773–2780.

    PubMed  CAS  Google Scholar 

  3. Park JG, Kramer BS, Lai SL, et al., 1990. Chemosensitivity patterns and expression of human multidrug resistance (associated MDR1) gene by human gastric and colorectal cell lines. J Natl Cancer Inst, 82:193–198.

    Article  PubMed  CAS  Google Scholar 

  4. Le Chevalier T, Smith FP, Harter WK, et al., 1985. Chemotherapy and combined modality therapy for locally advanced and metastatic gastric carcinoma. Semin Oncol 12:46–53.

    PubMed  Google Scholar 

  5. Wils J, Bleiberg H, 1989. Current status of chemotherapy for gastric cancer. Eur J Cancer Clin Oncol 25:3–8.

    Article  PubMed  CAS  Google Scholar 

  6. Moertel CG, Rubin J, O’Connell MJ, et al., 1986. A phase II study of combined 5-fluorouracil, doxorubicin, and cisplatin in the treatment of upper gastrointestinal adenocarci-noma. J Clin Oncol 4:1053–1057.

    PubMed  CAS  Google Scholar 

  7. Arbuck SG, 1989. Overview of clinical trials using 5-fluorouracil and leucovorin for the treatment of colorectal cancer. Cancer 63:1036–1044.

    Article  PubMed  CAS  Google Scholar 

  8. Bleyer WA, 1989. New vistas for leucovorin in cancer chemotherapy. Cancer 63:995–1007.

    Article  PubMed  CAS  Google Scholar 

  9. Park JG, Collins JM, Gazdar AF, et al., 1988. Enhancement of fluorinated pyrimidine-induced cytotoxicity by leucovorin in human colorectal carcinoma cell lines. J Natl Cancer Inst 80:1560–1564.

    Article  PubMed  CAS  Google Scholar 

  10. Berenberg JL, Goodman PJ, Oishi N, et al., 1989. 5-fluorouracil and folinic acid for the treatment of metastatic gastric cancer. Proc Am Soc Clin Oncol 8:101 (abstract).

    Google Scholar 

  11. Gottesman MM, Pastan I, 1988. The multidrug transporter, a double-edged sword. J Biol Chem 263:12163–12166.

    PubMed  CAS  Google Scholar 

  12. Fojo AT, Akiyama SI, Gottesman MM, Pastan I, et al., 1985. Reduced drug accumulation in multiple drug-resistant human KB carcinoma cell lines. Cancer Res 45:3002–3007.

    PubMed  CAS  Google Scholar 

  13. Fojo AT, Ueda K, Slamon DJ, et al., 1987. Expression of a multidrug-resistance gene in human tumors and tissues. Proc Natl Acad Sci USA 84:265–269.

    Article  PubMed  CAS  Google Scholar 

  14. Thiebault F, Tsuruo T, Hamada H, et al., 1987. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc Natl Acad Sci USA 84:7735–7738.

    Article  Google Scholar 

  15. Thiebault F, Tsuruo T, Hamada H. et al., 1988. Immunohistochemical localization in normal tissues of different epitopes in the mutidrug transport protein, pl70; Evidence for localization in brain capillaries and cross-reactivity of one antibody with a muscle protein. J Histochem Cytochem, in press.

    Google Scholar 

  16. Goldstein LJ, Galski H, Fojo A, et al., 1989. Expression of a multidrug resistance gene in human tumors. J Natl Cancer Inst 81:116–124.

    Article  PubMed  CAS  Google Scholar 

  17. Moscow JA, Fairchild CR, Madden MJ, et al., 1989. Expression of anionic glutathione-S-transferase and P-glycoprotein genes in human tissues and tumors. Cancer Res 49:1422–1428.

    PubMed  CAS  Google Scholar 

  18. Yamauchi M, Satta T, Yaguchi T, et al., 1989. Expression of a multidrug-resistance gene and effectiveness of anticancer agents in human stomach and colon cancer cell lines. Proc Am Assoc Cancer Res 30:518 (abstract).

    Google Scholar 

  19. Pastan I, Gottesman MM 1987. Multiple drug resistance in human cancer. New Engl J Med 316:1388–1393.

    Article  PubMed  CAS  Google Scholar 

  20. Mukhopadhyay T, Batsakis JG, Kuo MT, 1988. Expression of the MDR(P-glycoprotein) gene in Chinese hamster digestive tracts. J Natl Cancer Inst 80:269–275.

    Article  PubMed  CAS  Google Scholar 

  21. Kim YI, 1987. Histogenesis of gastric carcinomas among Koreans: A histotopographic analysis of 2370 cases. Korean J Pathol 20 (abstract).

    Google Scholar 

  22. Kim YI, 1987. Significance of histologie typing in gastric carcinoma: A useful parameter for prognostic determination and therapeutic implication. Korean J Gastroenterol 19:683–687.

    Google Scholar 

  23. Kim YI, Lee JB, 1977. A modified technique for pathologic approach in the investigation of early gastric cancer and chronic gastritis. J Korean Surg Soc 19:179–187.

    Google Scholar 

  24. Kim WH, Kim YI, 1988. Diagnostic accuracy of gastric endoscopie biopsy: Analysis of 818 gastric neoplasms with special reference to histologie discrepancy between endoscopie biopsy and resected stomach. Korean J Gastrointest Endoscopy 8:211–216.

    Google Scholar 

  25. Kim YI, Kim CJ, Kim WH. Histologie heterogeneity of gastric adenocarcinomas by depth of tumor invasion submitted for publication.

    Google Scholar 

  26. Oota K, Sobin LH, 1977. Histological typing of gastric and oesophageal tumors. In International Classification of Tumors No. 18, Geneva: World Health Organization, pp. 15–41.

    Google Scholar 

  27. Shirakabe H, Ichikawa H, Kumakura K, et al., 1966. Atlas of X-ray diagnosis of early gastric cancer, Philadelphia: J.B. Lipincott Co., p. 1.

    Google Scholar 

  28. Gold RP, Green PH, O’Toole KM, et al., 1984. Early gastric cancer; radiographic experience. Radiology 152:283–290.

    PubMed  CAS  Google Scholar 

  29. Kim JP, Park JG, Noh DY, et al., 1983. Early gastric cancer 137 cases. J Korean Cancer Res Assoc 15:42–49.

    Google Scholar 

  30. Choi BI, Kim JH, Han MC, et al., 1987. Radiological evaluation of early gastric cancer; analysis of 104 cases. J Korean Radiol Soc 23:424–431.

    Google Scholar 

  31. Shirakabe H, Maruyama M, 1982. Definition and classification of X-ray diagnosis of early gastric cancer. In (Shirakabe H, ed). Atlas of X-ray Diagnosis of Early Gastric Cancer. Tokyo: Igaku-Shoin, pp. 7–8.

    Google Scholar 

  32. Nishizawa M, Kariya, 1982. Diagnosis of gastric cancer. In (Shirakabe H, ed). Atlas of X-ray Diagnosis of Early Gastric Cancer. Tokyo: Igaku-Shoin, pp. 72–73.

    Google Scholar 

  33. Choi HJ, Moon YM, 1971. Endoscopic biopsy. Korean J Gastroenterol 4:1–7.

    Google Scholar 

  34. Takagi K, 1971. Limit of detection of minute gastric cancer of stomach cancer in mass survey. Gastroenterol Japonica 6:109.

    Google Scholar 

  35. Moon SE, 1985. A clinical analysis on adenocarcinoma of stomach. Pusan Medical J 25:83–95.

    Google Scholar 

  36. Cho MH, Park JG, Kim JP, 1989. Clinical evaluation of total gastrectomy and extended total gastrectomy for gastric cancer. J Korean Cancer Res Assoc 21:93–100.

    Google Scholar 

  37. Nishioka B, Watanabe S, Fujita Y, et al., 1979. Evaluation of resection of stomach and adjacent organs for advanced gastric cancer in special reference to splenectomy and pan-creaticosplenectomy. Jpn J Gastroenterol Surg 12:955–960.

    Article  Google Scholar 

  38. Koga S, Kaibara N, Kimura O,et al., 1981. Prognostic significance of combined splenectomy or pancreaticosplenectomy in total and proximal gastrectomy for gastric cancer. Am J Surg 142:546–550.

    Article  PubMed  CAS  Google Scholar 

  39. Suehiro S, Nagasue N, Ogawa Y, et al., 1984. The negative effect of splenectomy on the prognosis of gastric cancer. Am J Surg 148:645–648.

    Article  PubMed  CAS  Google Scholar 

  40. Kim SC, Kim SW, Bae SH, et al., 1989. The effect of splenectomy on the prognosis of gastric cancer. J Korean Cancer Res Assoc 21:74–81.

    Google Scholar 

  41. Chol SK, Park JG, Oh SK, et al., 1984. Esophagojejunostomy after total gastrectomy — Distal jejunal pouch. Korean J Gastroenterol 16:93–96.

    Google Scholar 

  42. Herfarth C, Schlag P, Buhl K, 1987. Surgical procedures for gastric substitution. World J Surg 11:689–698.

    Article  PubMed  CAS  Google Scholar 

  43. Yang HK, Park JG, Kim JP, 1989. Analysis of ten patients after total gastrectomy with jejunal interposition. Korean J Gastroenterol 21:76–80.

    Google Scholar 

  44. Oh ST, Kim JP, 1988. An analysis of lymph node metastasis of resected gastric carcinoma; 2467 cases. J Korean Surg Soc 35:145–151.

    Google Scholar 

  45. Kim JP, Park JG, 1983. Results of treatment of stomach cancer. J Korean Med Assoc 26:637–642.

    Google Scholar 

  46. Park JG, Kim JP, 1983. Reoperation for recurred stomach cancer. J Korean Cancer Res Assoc 15:64–69.

    Google Scholar 

  47. Lee CH, Park JG, Kim JP, 1987. Clinical study of reoperation for recurred stomach cancer. J Korean Cancer Res Assoc 19:107–113.

    CAS  Google Scholar 

  48. Preusser P, Achterrath W, Wilke H, et al., 1988. Chemotherapy of gastric cancer. Cancer Treat Rev 15:257–277.

    Article  PubMed  CAS  Google Scholar 

  49. Earl HM, Coombes RC, Schein PS, 1984. Cytotoxic chemotherapy for cancer of the stomach. Clin Oncol 3:351–369.

    CAS  Google Scholar 

  50. Cullinan SA, Moertel CG, Eleming TR, et al., 1985. A comparison of three chemothera-peutic regimens in the treatment of advanced pancreatic and gastric carcinoma: 5-fluorouracil vs 5-fluorouracil and doxorubicin vs 5-fluorouracil, doxorubicin, and mitomycin-c. JAMA 253:2061–2067.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Jae-Gahb Park
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Adi F. Gazdar
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yong-II Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Byung-Ihn Choi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. In-Sung Song
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Noe-Kyeong Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Sung-Tae Oh
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Jin-Pok Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. The Cancer Institute, Washington Hospital Center, Washington, DC, USA

    Paul H. Sugarbaker M.D., FACS

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer Science+Business Media New York

About this chapter

Cite this chapter

Park, JG. et al. (1991). Gastric cancer in Korea: experience at the Seoul National University Hospital. In: Sugarbaker, P.H. (eds) Management of Gastric Cancer. Cancer Treatment and Research, vol 55. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3882-0_16

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-3882-0_16

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-6731-4

  • Online ISBN: 978-1-4615-3882-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation